Skip to main content

Gross, but Appears to Work

Based on a small study, Amsterdam researchers find that fecal transplantation works better than vancomycin therapy to treat recurrent Clostridium difficile infections, which they report in The New England Journal of Medicine.

Forty-three patients were randomly assigned to receive donor feces, vancomycin, or vancomycin and bowel lavage treatment. Of the 16 patients who received donated feces, 13 were cured after their first treatment round, and 15 of the 16, or nearly 94 percent, were cured overall. In the vancomycin-only group, four of the 13 patients were cured, and, in the vancomycin plus lavage group, three of the 13 patients were cured.

Ed Yong at Not Exactly Rocket Science notes that the results were so impressive that the team stopped the study early and that all the patients eventually received the treatment.

The treatment is thought to work by altering the composition of the patients' gut microbiome. "The mechanism underlying the efficacy of donor-feces infusion is probably the reestablishment of the normal microbiota as a host defense against C. difficile," the researchers note in their paper, adding that "the fecal microbiota in patients with C. difficile infection had a reduced bacterial diversity, as compared with healthy persons, extending previous observations. Infusion of donor feces resulted in improvement in the microbial diversity, which persisted over time."

Fecal transplants have been used before to treat C. difficile infections, but there have been few controlled experiments, The New York Times adds.

"Those of us who do fecal transplant know how effective it is," Colleen Kelly, a gastroenterologist at the Women's Medicine Collaborative in Providence, RI, tells the Times. "The tricky part has been convincing everybody else."

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.